<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: prognoses</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Ultrasound to detect lung congestion in dialysis patients may help save lives</title>
   	 <description>Asymptomatic lung congestion increases dialysis patients' risks of dying prematurely or experiencing heart attacks or other cardiac events, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN). The study also found that using lung ultrasound to detect this congestion helps identify patients at risk.</description>
     <link>http://medicalxpress.com/news/2013-02-ultrasound-lung-congestion-dialysis-patients.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Thu, 28 Feb 2013 17:00:01 EST</pubDate>
	 <guid isPermaLink="false">news281289664</guid>
	 
</item>
<item>
     <title>New method halves wrongful cancer prognoses</title>
   	 <description>The number of incorrect cancer prognoses can be halved with computerised image analysis. In three years time, the method can be used on patients with bowel cancer, ovarian cancer and prostate cancer.</description>
     <link>http://medicalxpress.com/news/2013-02-method-halves-wrongful-cancer-prognoses.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 06 Feb 2013 08:12:39 EST</pubDate>
	 <guid isPermaLink="false">news279360748</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/newmethodhal.jpg" width="90" height="90" />
</item>
<item>
     <title>Novel therapeutic agents provide hope for patients with hard-to-treat blood disorders</title>
   	 <description>Encouraging safety and efficacy data on novel and emerging therapies presented at the 54th Annual Meeting of the American Society of Hematology (ASH) signal an important step forward in the development of treatment strategies for patients with hard-to-treat leukemia, myeloma, and myelofibrosis.</description>
     <link>http://medicalxpress.com/news/2012-12-therapeutic-agents-patients-hard-to-treat-blood.html</link>
	 <category>Cancer</category>
	 <pubDate>Sun, 09 Dec 2012 11:50:04 EST</pubDate>
	 <guid isPermaLink="false">news274274478</guid>
	 
</item>
<item>
     <title>Scientists identify genetic signatures for aggressive form of prostate cancer</title>
   	 <description>Scientists have discovered two separate genetic 'signatures' for prostate cancer that appear to be able to predict the severity of the disease, leading to hopes that in future, accuracy of prognosis and treatment of the disease could be greatly improved. Two Articles published in The Lancet Oncology reveal distinctive patterns of RNA—the genetic material that helps turn DNA into proteins—which appear to be able to predict whether patients have an aggressive prostate cancer, or whether they have a milder form of the disease.</description>
     <link>http://medicalxpress.com/news/2012-10-scientists-genetic-signatures-aggressive-prostate.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 08 Oct 2012 18:30:01 EST</pubDate>
	 <guid isPermaLink="false">news268913570</guid>
	 
</item>
<item>
     <title>Study provides roadmap for delirium risks, prevention, treatment, prognosis and research</title>
   	 <description>Delirium, a common acute condition with significant short- and long-term effects on cognition and function, should be identified as an indicator of poor long-term prognosis, prompting immediate and effective management strategies, according to the authors of a new systematic evidence review.</description>
     <link>http://medicalxpress.com/news/2012-09-roadmap-delirium-treatment-prognosis.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Tue, 18 Sep 2012 11:27:21 EST</pubDate>
	 <guid isPermaLink="false">news267186426</guid>
	 
</item>
<item>
     <title>Researchers test new drug for patients with neuroendocrine tumors</title>
   	 <description>A researcher at Moffitt Cancer Center and his international team of colleagues have reported study results on a novel multireceptor-targeted somatostatin analogue called pasireotide (SOM230) manufactured by Novartis Pharma AG. The Phase II, open-label, multicenter study in patients with advanced neuroendocrine tumors (NET) whose symptoms were no longer responsive to octreotide LAR therapy found that the drug was effective and well tolerated in controlling patient symptoms.</description>
     <link>http://medicalxpress.com/news/2012-08-drug-patients-neuroendocrine-tumors.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 06 Aug 2012 13:09:02 EST</pubDate>
	 <guid isPermaLink="false">news263477333</guid>
	 
</item>
<item>
     <title>Researchers find potential key to new treatment for mantle cell lymphoma</title>
   	 <description>Researchers at Moffitt Cancer Center and colleagues have demonstrated that the inhibition of signal transducer and activator of transcription 3 (STAT3) in mouse models of mantle cell lymphoma (MCL), an aggressive and incurable subtype of B-cell non-Hodgkin lymphoma that becomes resistant to treatment, can harness the immune system to eradicate residual malignant cells responsible for disease relapse.</description>
     <link>http://medicalxpress.com/news/2012-07-potential-key-treatment-mantle-cell.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 18 Jul 2012 12:16:58 EST</pubDate>
	 <guid isPermaLink="false">news261832609</guid>
	 
</item>
<item>
     <title>Research shows new prognosis tool for deadly brain cancer</title>
   	 <description>A diagnosis of glioblastoma multiforme (GBM) is generally a death sentence, but new research from the University of Wisconsin-Madison lab of Dr. John Kuo shows that at least one subtype is associated with a longer life expectancy. This discovery could help with better patient prognoses and lead to targeted drug treatments for GBM subtypes.</description>
     <link>http://medicalxpress.com/news/2012-06-prognosis-tool-deadly-brain-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 20 Jun 2012 12:31:43 EST</pubDate>
	 <guid isPermaLink="false">news259414294</guid>
	 
</item>
<item>
     <title>Family members of ICU patients too optimistic when faced with grim prognoses</title>
   	 <description>Family members of patients in the intensive care unit (ICU) tend to be overly optimistic about the possibility of recovery despite being told that the prognosis is grim, according to a study led by researchers at the University of Pittsburgh School of Medicine. The findings, reported in the March 6 issue of the Annals of Internal Medicine, indicate that family members try to sustain hope and harbor beliefs that their loved one will defy medical odds.</description>
     <link>http://medicalxpress.com/news/2012-03-family-members-icu-patients-optimistic.html</link>
	 <category>Health</category>
	 <pubDate>Mon, 05 Mar 2012 17:00:02 EST</pubDate>
	 <guid isPermaLink="false">news250166872</guid>
	 
</item>


</channel>
</rss>
